Current therapeutic and/or preventive strategies for DKD primarily involved glycemic control, blood pressure management, inhibition of the renin-angiotensin system, and reduction of cardiovascular risks; nevertheless, these interventions did not effectively halt the advancement of DKD or the onset of end-stage renal disease (Liu et al., 2022). The gene discussed is REN; the disease is chronic kidney disease.